Zynerba Pharmaceuticals (ZYNE)

[lumpy9200]

Unfortunately no gap up on that news tomorrow, as it wasn't actually new news. Yesterday (Tuesday) morning ZYNE did a press release saying that the phase 1/2 data, which they had already presented, was published in the Journal of Neurodevelopmental Disorders. It's excellent news for a variety of reasons when results from a trial are published, and I believe the press release is what drove the stock higher yesterday and today. It fell after hours on little volume, which means nothing IMHO. It's the CONNECT trial that will make or break for Fragile X, and I'm on record as saying that's why I bought this stock to begin with. So I'm very bullish on the company (just didn't want you thinking I'm a short hopping on here to spread doubt).

Best,
G